Klotho Neurosciences, Inc.
KLTO
$1.54
$0.042.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 482.71% | 817.19% | 570.40% | 110.58% | 90.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 482.71% | 817.19% | 570.40% | 110.58% | 90.64% |
| Operating Income | -482.71% | -817.19% | -570.40% | -110.58% | -90.64% |
| Income Before Tax | -538.96% | -769.30% | -514.62% | -104.22% | -86.35% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -538.96% | -769.30% | -514.62% | -104.22% | -86.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -538.96% | -769.30% | -514.62% | -104.22% | -86.35% |
| EBIT | -482.71% | -817.19% | -570.40% | -110.58% | -90.64% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -355.14% | -816.85% | -848.35% | -408.94% | -13,200.00% |
| Normalized Basic EPS | -354.91% | -819.37% | -846.20% | -408.93% | -12,375.00% |
| EPS Diluted | -346.76% | -772.94% | -846.76% | -420.67% | -13,550.00% |
| Normalized Diluted EPS | -354.91% | -819.37% | -846.20% | -408.93% | -12,375.00% |
| Average Basic Shares Outstanding | 43.94% | -93.15% | -97.05% | -98.06% | -98.55% |
| Average Diluted Shares Outstanding | 43.94% | -93.15% | -97.05% | -98.06% | -98.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |